logo
Select company
Select metric
$ 52.48MConsolidated Income
VS
Market
63
Sector
87
Industry
96
History
100
$ 34.65Close
$ 5.9 - $ 35.6 52-Week Range
Ticker Information

Ticker

STOK

Company Name

STOKE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

STOKE THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

STOK - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ 52.48M
3/31/2025$ 50.27M
12/31/2024$ -88.98M
9/30/2024$ -105.46M
6/30/2024$ -103.57M
3/31/2024$ -108.53M
12/31/2023$ -104.7M
9/30/2023$ -103.4M
6/30/2023$ -104.97M
3/31/2023$ -98.96M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • STOKE THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -47.84M.
  • Over the past 5 years, STOKE THERAPEUTICS INC's average Cons. Inc. has been $ -74.68M.
  • The median Cons. Inc. for STOKE THERAPEUTICS INC during this period was $ -95M
  • STOKE THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ 52.48M.
  • The lowest Cons. Inc. recorded by STOKE THERAPEUTICS INC in the same timeframe $ -108.53M

STOKE THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
AKBA : AKEBIA THERAPEUTICS INC $ -36.48MDAWN : DAY ONE BIOPHARMACEUTICALS INC $ -95MDNA : GINKGO BIOWORKS HOLDINGS INC $ -315.19MMRVI : MARAVAI LIFESCIENCES HOLDINGS INC $ -345.14MGERN : GERON CORP $ -88.01MKROS : KEROS THERAPEUTICS INC $ 18.77MNAGE : NIAGEN BIOSCIENCE INC $ 17.73MCRMD : CORMEDIX INC $ 51.16MIOVA : IOVANCE BIOTHERAPEUTICS INC $ -389.92MPHAT : PHATHOM PHARMACEUTICALS INC $ -330.15M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

STOK - Consolidated Income, Last 5 years

$ -108.53M

Minimum

Mar 31, 2024

$ 52.48M

Maximum

Jun 30, 2025

$ -74.68M

Average

$ -95M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.12M with a standard deviation of $ 116.68M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 378M
average$ 12.12M
median$ -2.09M
std$ 116.68M